Contents
pdf Download PDF
pdf Download XML
72 Views
12 Downloads
Share this article
Research Article | Volume 18 Issue 11 (November, 2026) | Pages 475 - 479
Prospective Validation Of The Heart Score For Risk Stratification In Acute Chest Pain: An Emergency Department Study
 ,
 ,
 ,
1
Assistant Professor, Department of Emergency Medicine, Shri Rawatpura Sarkar Institute of Medical Sciences and Research, Naya Raipur, Chhattisgarh, India.
2
Director and Head, Department of Emergency Medicine, Fortis Hospital, Mulund, Mumbai, India.
3
Assistant Professor, Department of Anesthesiology, Shri Rawatpura Sarkar Institute of Medical Sciences and Research, Naya Raipur, Chhattisgarh, India
4
Assistant Professor, Department of Anesthesiology, Shri Rawatpura Sarkar Institute of Medical Sciences and Research, Naya Raipur, Chhattisgarh, India.
Under a Creative Commons license
Open Access
Received
May 26, 2026
Revised
June 12, 2026
Accepted
July 14, 2026
Published
Nov. 21, 2026
Abstract

Background: Chest pain is a prevalent complaint that prompts visits to the emergency department, frequently triggering worries over acute coronary syndrome (ACS). (1) Swift and precise risk categorization in these instances is crucial to mitigate morbidity, mortality, and superfluous healthcare expenditures. Conventional risk ratings such as the Thrombolysis in Myocardial Infarction (TIMI) and the Global Registry of Acute Coronary Events (GRACE) have been widely utilized.(2),(3) Nonetheless, they frequently exhibit complexity, necessitating comprehensive information and specialized computations. Materials and Methods: The study encompassed adult male and female patients aged 18 and older who arrived at the emergency room with chest discomfort symptoms. Individuals experiencing severe chest pain, ST-elevation myocardial infarction (STEMI), or possessing diagnosed medical, surgical, or psychological problems necessitating hospitalization were omitted from the study. Upon arrival at the emergency department, patients' demographic information, clinical history, electrocardiogram (ECG) results, risk factors, and troponin levels were documented. The HEART score was computed for each patient according to these characteristics. The overall score was classified as low (0-3), moderate (4-6), or high risk (7-10). Results: A total of 157 individuals with chest discomfort who presented to the emergency room were enrolled in the study according to the inclusion criteria. The demographic and clinical attributes of the study cohort, as well as the distribution of the HEART score and the incidence of major adverse cardiac events (MACE) at six weeks, are outlined below. The study revealed that the predominant age group of patients was 51-60 years, comprising 24.2%, followed by 17.83% in the 41-50 years category. Conclusion: In conclusion, this study prospectively validates the HEART score as a reliable and practical tool for risk stratification of chest pain patients in an emergency department setting. The HEART score effectively identifies patients at low risk of MACE, reducing unnecessary admissions, and recognizes high-risk patients who require urgent intervention. The study findings support the integration of the HEART score into routine clinical practice for the management of chest pain patients.

Keywords
INTRODUCTION

Chest pain is a prevalent complaint that prompts visits to the emergency department, frequently triggering worries over acute coronary syndrome (ACS). (1) Swift and precise risk categorization in these instances is crucial to mitigate morbidity, mortality, and superfluous healthcare expenditures. Conventional risk ratings such as the Thrombolysis in Myocardial Infarction (TIMI) and the Global Registry of Acute Coronary Events (GRACE) have been widely utilized.(2),(3) Nonetheless, they frequently exhibit complexity, necessitating comprehensive information and specialized computations.

 

The HEART score (History, ECG, Age, Risk factors, Troponin) (Table 1) was established in the Netherlands in 2008 as a more efficient method for risk assessment in individuals with chest discomfort. The HEART score utilizes readily accessible clinical parameters to classify patients into low, moderate, and high-risk categories according to their probability of experiencing major adverse cardiac events (MACE), such as acute myocardial infarction, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and mortality.

 

HEART Score Interpretation (4)

  • Low Risk (0-3): Safe for discharge with outpatient follow-up.
  • Moderate Risk (4-6): Consider admission and further evaluation.
  • High Risk (7-10): Strong recommendation for aggressive treatment and early invasive strategies.

 

This study seeks to prospectively validate the HEART score within the Indian population attending a tertiary care emergency room. The HEART score, due to its simplicity, is anticipated to improve clinical decision-making, facilitating the early identification of high-risk patients and the safe discharge of low-risk patients. This study aims to demonstrate the utility of the strategy in emergency care settings by evaluating its predictive accuracy and comparing it with known clinical assessment techniques.

MATERIALS AND METHODS

This research was a prospective observational study carried out in the emergency department of a tertiary care hospital in Mumbai over an 18-month duration, from February 2018 to July 2019. The study sought to validate the HEART score for risk stratification in individuals presenting with chest discomfort. All emergency physicians received training in the application of the HEART score and were briefed on the research procedure.

 

The study encompassed adult male and female patients aged 18 and older who arrived at the emergency room with chest discomfort symptoms. Individuals experiencing severe chest pain, ST-elevation myocardial infarction (STEMI), or possessing diagnosed medical, surgical, or psychological problems necessitating hospitalization were omitted from the study.
Upon arrival at the emergency department, patients' demographic information, clinical history, electrocardiogram (ECG) results, risk factors, and troponin levels were documented. The HEART score was computed for each patient according to these characteristics. The overall score was classified as low (0-3), moderate (4-6), or high risk (7-10). A distinctive patient identity was employed to maintain confidentiality, and data were recorded in a standardized electronic format by the attending physicians.

 

The principal outcome measure was the incidence of major adverse cardiac events (MACE) within six weeks. MACE was characterized as acute myocardial infarction (AMI), coronary revascularization procedures (including percutaneous coronary intervention or coronary artery bypass grafting), and cardiac-related mortality. Patients were contacted via telephone after six weeks to assess these outcomes.

 

Statistical Analysis

The data were analyzed utilizing SPSS software, version 16.0. Descriptive statistics were expressed as mean ± standard deviation for continuous variables and as percentages for categorical variables. The incidence of MACE was categorized according to the HEART score classifications. Sensitivity, specificity, positive predictive value, and negative predictive value were computed for each range of the HEART score. Group differences were evaluated using the student’s t-test for continuous variables and the chi-square test for categorical variables. A p-value below 0.05 was deemed statistically significant.

 

RESULTS

A total of 157 individuals with chest discomfort who presented to the emergency room were enrolled in the study according to the inclusion criteria. The demographic and clinical attributes of the study cohort, as well as the distribution of the HEART score and the incidence of major adverse cardiac events (MACE) at six weeks, are outlined below. The study revealed that the predominant age group of patients was 51-60 years, comprising 24.2%, followed by 17.83% in the 41-50 years category. (Figure 1) The cohort aged 21-30 constituted 9.55% of the study population, whereas the demographic over 80 years accounted for 1.91%. The study population comprised 73.88% males and 26.12% females. (Table 2 )

Table 2: Baseline characteristics of the study population

Characteristic

Value

Age (mean ± SD)

55.6 ± 12.4 years

Gender (Male/Female)

116 (73.9%) / 41 (26.1%)

Hypertension

41 (26.1%)

Diabetes Mellitus

13 (8.3%)

History of Smoking

65 (41.4%)

Hyperlipidemia

20 (12.7%)

Family History of CAD

47 (29.9%)

 

The HEART score was calculated for each patient, and the study population was stratified into low, moderate, and high-risk categories: (Figure 2)

  • Low risk (0-3):2% (n = 38)
  • Moderate risk (4-6):04% (n = 77)
  • High risk (7-10):75% (n = 42)

At six weeks, a total of 45.86% (n = 72) of the patients experienced MACE. (Figure 3) Among these:

  • 57% (n = 37) underwent coronary angiography (CAG).
  • 01% (n = 22) underwent percutaneous transluminal coronary angioplasty (PTCA).
  • 82% (n = 7) underwent coronary artery bypass grafting (CABG).
  • 46% (n = 7) experienced a myocardial infarction (MI).

No deaths were reported among the study population during the six-week follow-up period.

The study found a significant correlation between the HEART score and the occurrence of MACE:

  • Low-risk category (0-3): Only 2 patients (5.26%) experienced MACE.
  • Moderate-risk category (4-6): 30 patients (38.96%) experienced MACE.
  • High-risk category (7-10): 40 patients (95.24%) experienced MACE.

 

The sensitivity, specificity, positive predictive value, and negative predictive value of the HEART score for predicting MACE were calculated:

  • For low-risk scores (0-3), the sensitivity was 2.78%, and specificity was 57.65%.
  • For moderate-risk scores (4-6), the sensitivity was 41.67%, and specificity was 44.71%.
  • For high-risk scores (7-10), the sensitivity was 55.56%, and specificity was 97.65%.

The results demonstrated that patients in the high-risk category were more likely to experience MACE, with a statistically significant p-value of <0.001.

The study found that co-morbidities like hypertension and diabetes were significant risk factors for MACE. Patients with a history of hypertension had a MACE rate of 43.9%, while those with both diabetes and hypertension had a MACE rate of 60%. Additionally, patients with a combination of diabetes, hypertension, and a history of ischemic heart disease showed a 100% occurrence of MACE at six weeks. The study demonstrated a clear correlation between the HEART score and the incidence of MACE within six weeks. Patients with higher HEART scores were more likely to experience MACE, thereby validating the utility of the HEART score for risk stratification in chest pain patients

DISCUSSION

The HEART score is a straightforward and effective clinical instrument for risk classification of chest pain patients in the emergency department (ED).(4) This study aimed to validate the efficacy of the HEART score in predicting the risk of major adverse cardiac events (MACE) within six weeks in an Indian tertiary care environment. This study illustrates that the HEART score proficiently distinguishes low-risk patients suitable for safe discharge from high-risk patients who may necessitate early invasive intervention. The findings of this study correspond with prior international research that identified the HEART score as a dependable and effective instrument.

 

Diverse risk scores, including as the TIMI and GRACE scores, are extensively utilized for stratifying the risk of acute coronary syndrome (ACS) in emergency department patients.(5) These scores were primarily intended for individuals already diagnosed with acute coronary syndrome or admitted to coronary care units. They frequently necessitate numerous laboratory values, which may not be readily accessible. The HEART score is based on five essential parameters: history, ECG findings, age, risk factors, and troponin levels, facilitating prompt and efficient decision-making. The utilization of easily accessible clinical data enables the rapid calculation of the HEART score within minutes of the patient's arrival at the emergency department, rendering it a more pragmatic option in time-critical situations.(6)

 

In this investigation, patients were categorized into low (0-3), moderate (4-6), and high (7-10) risk groups. The research established a substantial correlation between elevated HEART scores and the incidence of MACE within a six-week period. Patients with elevated scores (7-10) exhibited a 95.24% incidence of MACE, underscoring the HEART score's efficacy in identifying those at significant risk necessitating intensive care. The low-risk group (0-3) exhibited a MACE incidence of merely 5.26%, demonstrating that the HEART score proficiently identifies low-risk patients suitable for conservative management.

 

The constituent elements of the HEART score—history, ECG findings, age, risk factors, and troponin levels—are essential in forecasting adverse cardiac events.(1) This study found that patients with extremely suspicious histories and notable ECG alterations were more prone to have MACE. The research highlighted the significance of increased troponin levels as an indicator of myocardial damage. Patients exhibiting troponin levels over three times the usual threshold had a markedly increased risk of major adverse cardiovascular events (MACE) in comparison to individuals with normal or modestly raised troponin levels.

 

Risk variables included diabetes mellitus, hypertension, smoking, hypercholesterolemia, and a familial history of coronary artery disease were significant in forecasting major adverse cardiovascular events (MACE). The findings indicated an increased occurrence of MACE in individuals with multiple risk factors, highlighting the cumulative impact of these factors on cardiovascular risk. This finding aligns with the current research, which recognizes these risk factors as significant contributors to coronary artery disease. (3)(5)

 

This study assessed the sensitivity and specificity of the HEART score across each risk group. The high-risk group (scores of 7-10) had a sensitivity of 55.56% and a specificity of 97.65%, signifying that the HEART score proficiently identifies patients at elevated risk of developing MACE. The positive predictive value (PPV) and negative predictive value (NPV) for this category were 95.24% and 72.17%, respectively. These findings highlight the HEART score's effectiveness in distinguishing high-risk individuals necessitating intrusive interventions from low-risk patients eligible for safe release.

 

The research indicated that the low-risk group (scores of 0-3) exhibited a specificity of 57.65% and a sensitivity of 2.78%. Despite the low sensitivity, the negative predictive value of 41.18% reinforces the idea that low-risk patients are improbable to encounter MACE. These findings confirm the HEART score as an effective instrument for identifying low-risk patients and reducing unnecessary hospital admissions.

 

The study findings hold considerable ramifications for clinical practice within the emergency department. The HEART score facilitates emergency physicians in making educated decisions about patient management, thereby minimizing unnecessary admissions and maximizing resource use. The elevated specificity of the HEART score for high-risk patients indicates its efficacy in identifying individuals necessitating urgent interventions, such as coronary angiography or revascularization treatments.

Furthermore, the capacity to rapidly compute the HEART score utilizing readily accessible clinical data renders it an optimal instrument in high-traffic emergency departments. Incorporating the HEART score into standard clinical practice can enhance patient outcomes, lower expenses, and increase patient satisfaction by minimizing unnecessary hospital admissions.

 

Our study had several limitations. This research was performed at a singular tertiary care hospital located in an urban environment, thereby constraining the applicability of the results to different populations, especially those in rural or disadvantaged regions where patient demographics and healthcare accessibility may vary. The study group predominantly comprised urban patients, rendering the results potentially inapplicable to rural populations with distinct socioeconomic and lifestyle variables. Additional multicentric research with varied populations are necessary to confirm these results.

 

A further limitation of the study is the comparatively little follow-up duration of six weeks. While six weeks is a typical duration for assessing MACE in risk stratification studies, extended follow-up periods might yield a more thorough comprehension of the HEART score's predictive validity.

 

Notwithstanding its constraints, this study possesses numerous strengths. This represents one of the initial prospective validations of the HEART score within an Indian population, underscoring its applicability in a practical clinical environment. The study's prospective design and meticulous patient follow-up yield substantial evidence endorsing the efficacy of the HEART score. The substantial sample size and meticulous statistical analysis of the study bolster the validity and dependability of the results.

 

The results of this study correspond with prior international research that evidenced the efficacy of the HEART score in forecasting MACE. For example, research by Six et al.(2) and Backus et al.(5) in the Netherlands demonstrated analogous connections between elevated HEART scores and a heightened occurrence of MACE. Moreover, the study results align with validation studies performed in many populations, encompassing global research and retrospective analysis.

CONCLUSION

In conclusion, this study prospectively validates the HEART score as a reliable and practical tool for risk stratification of chest pain patients in an emergency department setting. The HEART score effectively identifies patients at low risk of MACE, reducing unnecessary admissions, and recognizes high-risk patients who require urgent intervention. The study findings support the integration of the HEART score into routine clinical practice for the management of chest pain patients.

Future research should focus on validating the HEART score in diverse populations, including rural and lower socioeconomic groups, to enhance its generalizability. Additionally, further studies with extended follow-up periods are needed to evaluate the long-term predictive accuracy of the HEART score. Multicentric trials involving a larger patient population would also provide stronger evidence for its utility in different clinical settings.

REFERENCES
  1. Mahler SA, Lenoir KM, Wells BJ, Burke GL, Duncan PW, Case LD, et al. Safely identifying emergency department patients with acute chest pain for early discharge: HEART score performance in the HEART pathway trial. Acad Emerg Med. 2019;26(1):78-86.
  2. Six AJ, Backus BE, Doevendans PA. The HEART score for chest pain patients in the emergency department: A practical approach to the assessment of risk. Neth Heart J. 2018;26(4):191-6.
  3. Poldervaart JM, Langedijk M, Backus BE, Dekker IM, Six AJ, Doevendans PA, et al. Comparison of the HEART and TIMI risk scores for chest pain patients at the emergency department: A multicenter validation study. Ann Emerg Med. 2019;74(5):688-96.
  4. Stopyra JP, Riley RF, Hiestand BC, Mahler SA, Hoekstra JW, Lefebvre CW, et al. Validation of the no objective testing rule and comparison to the HEART Pathway. Acad Emerg Med. 2020;27(1):19-28.
  5. Backus BE, Poldervaart JM, Six AJ, Bosschaert MA, Mast EG, Mosterd A, et al. The HEART score for early rule out of acute coronary syndromes in the emergency department: A multinational validation study. Eur Heart J Acute Cardiovasc Care. 2020;9(4):312-20.
  6. Greenslade JH, Carlton EW, Van Hise C, Cho E, Hawkins T, Parsonage W, et al. HEART score and the two-hour accelerated diagnostic protocol for chest pain assessment: Either pathway is safe. Heart. 2018;104(1):60-6.
Recommended Articles
Research Article
Comparison of Frailty Status in Patients Undergoing Elective Versus Emergency General Surgery
...
Published: 20/11/2026
Research Article
Magnetic Resonance Imaging in the Diagnostic Evaluation of Non-Traumatic Low Back Pain: A Prospective Observational Study.
...
Published: 21/11/2026
Research Article
Comparison of Right Ventricular Dysfunction Between Patients with Acute Exacerbation and Stable Chronic Obstructive Pulmonary Disease Using Echocardiography
...
Published: 20/11/2026
Research Article
Comparative Assessment of Fracture Resistance and Crack Propagation in Mandibular Premolars Obturated with Single-Cone and Warm Vertical Compaction Techniques Using Bioceramic Sealer
...
Published: 20/11/2026
Chat on WhatsApp
© Copyright CME Journal Geriatric Medicine